Literature DB >> 2625480

Isocratic high-performance liquid chromatographic determination of the concentration and specific radioactivity of phosphoenolpyruvate and uridine diphosphate glucose in tissue extracts.

A Giaccari1, L Rossetti.   

Abstract

A rapid and efficient isocratic high-performance liquid chromatographic method for studying the metabolism of phosphoenolpyruvate and uridine diphosphate glucose (UDPG) has been developed. For each compound this method can measure tissue concentrations in the range 0.1-1000 nmol/g of tissue and determine specific radioactivity. All measurements can be performed in 200 mg of tissue. The recoveries of uridine diphosphate [6-3H]glucose and phosphoenol[1-14C]pyruvate from liver tissue homogenates were 97 and 99%, respectively. Following intra-arterial infusion of [6-3H]glucose and [U-14C]lactate in conscious rat, the concentration and specific radioactivity of phosphoenolpyruvate and UDPG were determined in rat liver. The method may be applied to experimentation in small animals using radiolabelled precursors in order to quantitate in vivo the glycogenic and gluconeogenic fluxes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2625480     DOI: 10.1016/0378-4347(89)80006-4

Source DB:  PubMed          Journal:  J Chromatogr


  10 in total

1.  Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.

Authors:  L Rossetti; A E Stenbit; W Chen; M Hu; N Barzilai; E B Katz; M J Charron
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

2.  Enhanced activation of a "nutrient-sensing" pathway with age contributes to insulin resistance.

Authors:  Francine H Einstein; Sigal Fishman; Jeffery Bauman; Reid F Thompson; Derek M Huffman; Gil Atzmon; Nir Barzilai; Radhika H Muzumdar
Journal:  FASEB J       Date:  2008-06-19       Impact factor: 5.191

3.  Role of the glucosamine pathway in fat-induced insulin resistance.

Authors:  M Hawkins; N Barzilai; R Liu; M Hu; W Chen; L Rossetti
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

Review 4.  The Role of Circulating Amino Acids in the Hypothalamic Regulation of Liver Glucose Metabolism.

Authors:  Isabel Arrieta-Cruz; Roger Gutiérrez-Juárez
Journal:  Adv Nutr       Date:  2016-07-15       Impact factor: 8.701

5.  Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance.

Authors:  Roger Gutiérrez-Juárez; Alessandro Pocai; Claudia Mulas; Hiraku Ono; Sanjay Bhanot; Brett P Monia; Luciano Rossetti
Journal:  J Clin Invest       Date:  2006-06       Impact factor: 14.808

6.  In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats.

Authors:  L Rossetti; M Hawkins; W Chen; J Gindi; N Barzilai
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

7.  Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes.

Authors:  L Rossetti; A Giaccari; N Barzilai; K Howard; G Sebel; M Hu
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

8.  A novel experimental strategy to assess the metabolic effects of selective activation of a G(q)-coupled receptor in hepatocytes in vivo.

Authors:  Jian Hua Li; Shalini Jain; Sara M McMillin; Yinghong Cui; Dinesh Gautam; Wataru Sakamoto; Huiyan Lu; William Jou; Owen P McGuinness; Oksana Gavrilova; Jürgen Wess
Journal:  Endocrinology       Date:  2013-07-16       Impact factor: 4.736

9.  Predominant role of gluconeogenesis in the hepatic glycogen repletion of diabetic rats.

Authors:  A Giaccari; L Rossetti
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

10.  Skeletal muscle glycogenolysis is more sensitive to insulin than is glucose transport/phosphorylation. Relation to the insulin-mediated inhibition of hepatic glucose production.

Authors:  L Rossetti; M Hu
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.